BeStock  
Stocks › Biotechnology › ALNY

Alnylam Pharmaceuticals ALNY

US equityMarket cap rank #427Biotechnology
$236.56 −$10.18 (-4.13%)
Market open · Oct 1, 1:10 pm ET · After hours $246.74 0.00%
Open$248.21
Prev close$246.74
Day range$233.53 – $251.71
Volume860.4K
Market cap$31.65B
P/E (TTM)41.2
Dividend yield–

Analyst view

ConsensusBuy
Analysts21
Average target$369.96+56.4% vs. price
  • Buy 86%
  • Hold 14%
Low $230.00Now $236.56Avg $369.96High $489.00

Recent rating changes

The last 20 actions on file set price targets from $300.00 to $489.00, averaging $371.79.

DateFirmRatingTarget
30 Sep 2026 Cantor Fitzgerald HOLD $325.00
30 Sep 2026 J.P. Morgan BUY $369.00
25 Sep 2026 Bernstein BUY $376.00
21 Sep 2026 H.C. Wainwright BUY $455.00
18 Sep 2026 Truist Financial BUY –
17 Sep 2026 Needham BUY $357.00
17 Sep 2026 BMO Capital BUY $318.00
16 Sep 2026 Bernstein BUY $376.00
11 Sep 2026 Morgan Stanley HOLD $300.00
2 Sep 2026 H.C. Wainwright BUY $455.00
1 Sep 2026 Barclays BUY $450.00
31 Aug 2026 Piper Sandler BUY $489.00
31 Aug 2026 BofA Securities BUY $346.00
31 Aug 2026 Truist Financial BUY –
31 Aug 2026 Evercore BUY $325.20
31 Aug 2026 Stifel BUY $318.00
31 Aug 2026 Citi BUY $340.00
30 Aug 2026 BofA Securities BUY $346.00
30 Aug 2026 BMO Capital BUY $318.00
28 Aug 2026 CCORF BUY $429.00

Discussion

No comments yet — be the first to weigh in on ALNY.

Leave a comment

Scroll to Top